Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.01%189.03B | -0.36%741.75B | -3.89%190.5B | -5.26%177.7B | 1.29%176.62B | 6.88%196.94B | -1.56%744.4B | 3.83%198.21B | -7.59%187.57B | 6.67%174.36B |
Cost of revenue | -9.48%39.76B | -12.65%155.33B | -6.38%36.11B | -16.81%38.88B | -19.29%36.43B | -7.35%43.92B | 1.72%177.84B | -23.99%38.57B | 5.68%46.74B | 11.11%45.13B |
Gross profit | -2.45%149.27B | 3.50%586.42B | -3.29%154.39B | -1.43%138.82B | 8.48%140.19B | 11.81%153.02B | -2.55%566.57B | 13.90%159.64B | -11.28%140.84B | 5.21%129.23B |
Operating expense | 6.99%135.86B | 1.23%533.01B | 3.82%138.52B | 0.34%132.71B | 2.57%134.79B | -1.88%126.99B | -0.21%526.53B | -17.01%133.42B | -8.86%132.27B | 11.88%131.41B |
Selling and administrative expenses | 15.64%99.54B | 4.50%374.42B | 21.17%103.38B | -0.44%92.17B | 5.34%92.79B | -6.74%86.08B | -2.22%358.29B | -22.62%85.32B | -8.77%92.58B | 10.28%88.08B |
-General and administrative expense | 15.64%99.54B | 4.50%374.42B | 21.17%103.38B | -0.44%92.17B | 5.34%92.79B | -6.74%86.08B | -2.22%358.29B | -22.62%85.32B | -8.77%92.58B | 10.28%88.08B |
Research and development costs | 1.43%41.74B | -2.30%169.02B | -13.66%44.55B | 4.55%41.7B | -3.23%41.63B | 6.88%41.15B | 0.73%173B | 6.47%51.6B | -8.01%39.89B | 12.85%43.02B |
Other operating expenses | -70.50%118M | -55.86%1.57B | -15.41%1.2B | ---- | -41.50%516M | -62.86%400M | -13.93%3.55B | -44.69%1.42B | -76.93%167M | --882M |
Total other operating income | 761.99%5.53B | 44.33%12B | 115.91%10.61B | 214.13%1.16B | -75.44%140M | -73.90%642M | -43.24%8.31B | 820.41%4.92B | -16.74%368M | 6.34%570M |
Operating profit | -48.48%13.41B | 33.38%53.41B | -39.47%15.87B | -28.72%6.11B | 347.64%5.4B | 250.06%26.03B | -25.51%40.04B | 227.27%26.22B | -37.11%8.57B | -140.52%-2.18B |
Net non-operating interest income (expenses) | 13.46%2.56B | 69.23%8.42B | 87.65%2.26B | 116.93%1.92B | 232.15%1.97B | -1.27%2.26B | 601.41%4.97B | 4,724.00%1.21B | 264.61%886M | 800.00%594M |
Non-operating interest income | 17.54%3.28B | 49.25%10.8B | 55.48%3.11B | 54.59%2.33B | 147.89%2.58B | 3.49%2.79B | 201.50%7.24B | 274.34%2B | 132.10%1.5B | 121.70%1.04B |
Non-operating interest expense | 34.91%715M | 5.38%2.39B | 6.56%845M | -34.79%403M | 36.16%610M | 30.22%530M | 33.92%2.27B | 55.80%793M | 52.59%618M | 10.89%448M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -43.54%15.97B | 37.35%61.82B | -33.87%18.13B | -15.06%8.03B | 564.52%7.37B | 190.94%28.29B | -17.35%45.01B | 233.28%27.42B | -31.82%9.46B | -129.12%-1.59B |
Income tax | -39.62%4.46B | 252.57%18.04B | -55.26%5.15B | 321.32%1.4B | 175.70%4.1B | 140.47%7.39B | -235.27%-11.82B | 267.83%11.51B | -60.17%333M | -516.28%-5.42B |
Net income | -44.93%11.51B | -22.96%43.78B | -18.40%12.98B | -27.33%6.63B | -14.69%3.27B | -25.27%20.9B | 24.32%56.84B | 215.99%15.91B | -30.01%9.12B | -7.60%3.83B |
Net income continuous operations | -44.93%11.51B | -22.97%43.78B | -18.40%12.98B | -27.34%6.63B | -14.71%3.27B | -25.28%20.9B | 24.32%56.84B | 216.00%15.91B | -30.01%9.12B | -7.57%3.83B |
Noncontrolling interests | 65.60%929M | -1.92%1.38B | 21.12%-325M | 38.00%661M | 81.82%480M | -47.67%561M | 162.76%1.4B | 71.93%-412M | 142.54%479M | 23.94%264M |
Net income attributable to the company | -47.98%10.58B | -23.50%42.41B | -18.46%13.31B | -30.95%5.97B | -21.83%2.79B | -24.38%20.34B | 15.59%55.43B | 233.26%16.32B | -38.95%8.64B | -9.30%3.57B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 1M | 1M | 0 | -1M | 0.00%1M | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -47.98%10.58B | -23.50%42.41B | -18.47%13.31B | -30.95%5.97B | -21.80%2.79B | -24.38%20.34B | 15.59%55.43B | 233.26%16.32B | -38.95%8.64B | -9.30%3.57B |
Gross dividend payment | ||||||||||
Basic earnings per share | -47.90%36.95 | -23.51%147.86 | -18.48%46.4 | -30.96%20.81 | 58.60%19.73 | -24.40%70.92 | 15.57%193.31 | 233.23%56.92 | -84.74%30.14 | -77.33%12.44 |
Diluted earnings per share | -47.90%36.95 | -23.51%147.86 | -18.48%46.4 | -30.96%20.81 | 58.60%19.73 | -24.40%70.92 | 15.58%193.31 | 233.23%56.92 | -84.74%30.14 | -77.33%12.44 |
Dividend per share | 0 | 0.00%160 | 0.00%80 | 0 | 0.00%80 | 0 | 0.00%160 | 0.00%80 | 0 | 0.00%80 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |